Researcher
Pieter De Pauw
- Keywords:Applied biological sciences, biotechnology, Medicine, General and logistic services
Affiliations
- Diabetes Pathology & Therapy (Research group)
Member
From15 Apr 2021 → Today - Clinical sciences (Department)
Member
From31 Jan 2024 → 14 Apr 2024 - Vriendenkring VUB (Office)
Member
From1 Apr 2023 → Today - Pathology/molecular and cellular medicine (Department)
Member
From15 Apr 2021 → 14 Apr 2024 - Pathology/molecular and cellular medicine (Department)
Member
From15 Apr 2021 → 20 Oct 2022 - Department of Bio-engineering Sciences (Department)
Member
From8 Apr 2019 → 30 Sep 2023 - Department of Bio-engineering Sciences (Department)
Member
From1 Oct 2011 → 14 Apr 2021 - Medical Biochemistry (Department)
Member
From1 Oct 2000 → 31 Aug 2009
Publications
1 - 10 of 12
- Baseline plasma proinsulin response to glucose for predicting therapeutic response to otelixizumab in recent-onset type 1 diabetes(2023)
Authors: Aster Desouter, Bart Keymeulen, Simke Demeester, Pieter De Pauw, Annelien Van Dalem, Bruno Lapauw, Christophe De Block, Pieter Gillard, Danny Pipeleers, Frans K Gorus
- Development of Neutralizing Multimeric Nanobody Constructs Directed against IL-13(2021)
Authors: Philippe J-L Y Gevenois, Pieter De Pauw, Steve Schoonooghe, Cédric Delporte, Thami Sebti, Karim Amighi, Serge Muyldermans, Nathalie Wauthoz
Pages: 2608-2620 - Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin: C-Peptide Ratio (vol 11, e0166702, 2016)(2017)
Authors: Annelien Van Dalem, Simke Demeester, Eric V Balti, Bart Keymeulen, Pieter Gillard, Bruno Lapauw, Christophe De Block, Pascale Abrams, Eric Weber, Ilse Vermeulen, et al.
- Prediction of Impending Type 1 Diabetes through Automated Dual-Label Measurement of Proinsulin:C-Peptide Ratio(2016)
Authors: Annelien Van Dalem, Simke Demeester, Eric V Balti, Bart Keymeulen, Pieter Gillard, Bruno Lapauw, Christophe De Block, Pascale Abrams, Eric Weber, Ilse Vermeulen, et al.
- Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies(2016)
Authors: Ema Romao, Francisco Morales-Yánez, Yaozhong Hu, Maxine Crauwels, Pieter De Pauw, Gholamreza Ghassanzadeh Hassanzadeh, Nick Devoogdt, Chloé Ackaert, Cécile Vincke, Serge Muyldermans
Pages: 6500-6518 - Plasma GAD65, marker for early beta cell loss following intraportal islet cell transplantation in diabetic patients(2015)
Authors: Zhidong Ling, Pieter De Pauw, Daniel Jacobs-Tulleneers Thevissen, Rui Mao, Pieter Gillard, Christiane S Hampe, Geert Martens, Pieter in 't Veld, Åke Lernmark, Bart Keymeulen, et al.
Pages: 2314-2321 - Development of a multipurpose time-resolved fluorescence immunoassay for rat insulin(2010)
Authors: Farah Van Genderen, Ilse Vermeulen, Evilien Vekens, Pieter De Pauw, Christiaan Van Schravendijk
Pages: 8-13 - Hyperglycaemic clamp test for diabetes risk assessment in IA-2-antibody-positive relatives of type 1 diabetic patients(2010)
Authors: E. Vandemeulebroucke, K. Decochez, C. De Block, F. Féry, Ilse Vermeulen, Pieter De Pauw, Chantal Mathieu
Pages: 36-44 - Functional beta-cell mass and insulin sensitivity is decreased in insulin-independent pancreas-kidney recipients.(2009)
Authors: E. Vandemeulebroucke, Pieter De Pauw, Chantal Mathieu
Pages: 402-407 - Total error profiling of a proinsulin time-resolved fluorescence immunoassay.(2009)
Authors: Pieter De Pauw, R. Mackin, Patrick Goubert, Christiaan Van Schravendijk
Pages: 2403-2406